POSTOPERATIVE ADJUVANT TREATMENT
Clinical trials for POSTOPERATIVE ADJUVANT TREATMENT explained in plain language.
Never miss a new study
Get alerted when new POSTOPERATIVE ADJUVANT TREATMENT trials appear
Sign up with your email to follow new studies for POSTOPERATIVE ADJUVANT TREATMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for head and neck cancer patients who Can't take chemo
Disease control Recruiting nowThis phase 3 trial tests a new treatment for people with high-risk head and neck cancer who cannot receive the standard chemotherapy drug cisplatin. Participants receive radiation therapy combined with two drugs (nimotuzumab and benmelstobart) to see if this approach improves dis…
Matched conditions: POSTOPERATIVE ADJUVANT TREATMENT
Phase: PHASE3 • Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
New drug cocktail may cut pain and inflammation after bariatric surgery
Symptom relief Recruiting nowThis study tests whether giving a combination of two drugs (lidocaine and dexmedetomidine) during weight-loss surgery can lower pain, inflammation, and cell stress afterward. About 104 adults having laparoscopic bariatric surgery will be randomly assigned to receive the combo, on…
Matched conditions: POSTOPERATIVE ADJUVANT TREATMENT
Phase: PHASE4 • Sponsor: Instituto Mexicano del Seguro Social • Aim: Symptom relief
Last updated Jun 15, 2026 18:55 UTC